Read + Share
Bradshaw D, Abramowicz I, Bremner S, Verma S, et al. Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in
people with HIV and non-alcoholic fatty liver disease. PLoS One 2023;18:e0288598.
PMID: 37450478
|
 |
|
Bradshaw D, Abramowicz I, Bremner S, Verma S, et al. Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in
people with HIV and non-alcoholic fatty liver disease. PLoS One 2023;18:e0288598.
PMID: 37450478
|
|
|
|